Wegovy®
semaglutide
- Form
- Weekly injection; daily tablet
- Approved for
- Chronic weight management; reducing the risk of major cardiovascular events in adults with heart disease and obesity or overweight
An independent, licensed clinician reviews your secure online health assessment and, only if it's clinically appropriate, prescribes an FDA-approved, brand-name GLP-1 medication — dispensed by a state-licensed U.S. pharmacy, with ongoing follow-up care.
Medical weight management that follows the same order a good clinic would — assessment first, medication only if it fits, and follow-up for as long as you're in care.
Complete a secure health assessment about your history, current medications, and goals — from home, in a few minutes.
A clinician licensed in your state reviews it, may ask for recent labs or a video visit, and talks through your options.
If an FDA-approved GLP-1 medication is a good clinical fit, your clinician prescribes it. If not, they'll explain why.
A state-licensed U.S. pharmacy fills your prescription and ships it to you with the Medication Guide.
Regular check-ins to review how you feel, manage side effects, and adjust your dose when appropriate.
Clinicians prescribe only FDA-approved products, each for the use it is approved for. Whether one is right for you — and which — is a decision you make with your clinician.
Approved for adults with obesity, or with overweight and a weight-related condition, alongside a reduced-calorie diet and increased physical activity.
semaglutide
tirzepatide (GIP/GLP-1)
liraglutide
orforglipron
FDA-approved to improve blood sugar control in adults with type 2 diabetes. They are prescribed only as part of type 2 diabetes care — never for weight management.
semaglutide
semaglutide
tirzepatide
dulaglutide
liraglutide
Prescription only, and only if clinically appropriate. Availability depends on your health history, your state, and pharmacy supply. Please review the Important Safety Information, including the boxed warning, and each product's full Prescribing Information and Medication Guide. Wegovy®, Ozempic®, Rybelsus®, Saxenda® and Victoza® are registered trademarks of Novo Nordisk A/S. Zepbound®, Mounjaro®, Trulicity® and Foundayo™ are trademarks of Eli Lilly and Company. Coravita Health is not affiliated with or endorsed by these manufacturers.
Coravita Health provides the telehealth platform and patient support. Coravita Health does not practice medicine; all diagnosis, prescribing and treatment decisions are made by independent, licensed clinicians. Prescriptions are dispensed by state-licensed U.S. pharmacies.
Your care is directed by independent clinicians licensed in your state. They review your history, decide whether treatment is appropriate, and own every prescribing decision. No one on the Coravita Health business team can change that.
Prescriptions are dispensed by state-licensed U.S. pharmacies, using FDA-approved, brand-name products.
Health information is collected through a secure intake and shared only with your treating clinician and dispensing pharmacy.
Follow-up care with your clinician, dose adjustments when appropriate, and patient support by phone and email.
GLP-1 medications are approved for use with a reduced-calorie diet and more activity. We help with both, in realistic steps.
Weight-management GLP-1 medications are approved for adults who meet the criteria below. Your clinician determines eligibility after reviewing your full health history.
Adults with a body mass index (BMI) of 30 or higher.
Adults with a BMI of 27 or higher and at least one weight-related condition, such as high blood pressure, type 2 diabetes, or high cholesterol.
These reflect the FDA-approved labeling for weight-management products, used together with a reduced-calorie diet and increased physical activity. Meeting them does not mean a prescription will be written — your clinician determines eligibility.
The first prescription is a starting point, not the finish line. Follow-up care continues as your body and your routine change.
Yes. Every medication on this site is prescription-only. A licensed clinician must review your health information and decide whether one is clinically appropriate for you.
Only FDA-approved, brand-name products, each for its approved use. For chronic weight management, clinicians may consider Wegovy®, Zepbound®, Saxenda® or Foundayo™. For type 2 diabetes care, they may consider Ozempic®, Rybelsus®, Mounjaro®, Trulicity® or Victoza®.
No. Ozempic®, Rybelsus®, Mounjaro®, Trulicity® and Victoza® are FDA-approved for type 2 diabetes, and they are prescribed only as part of type 2 diabetes care.
No. Prescriptions are written only when your clinician decides treatment is clinically appropriate. If it isn't, your clinician will explain why and talk through other options.
Coverage varies by plan. We can help check whether your pharmacy benefit covers a prescribed medication.
Yes. Health information is collected through a secure intake, handled under HIPAA-aligned safeguards, and shared only with your treating clinician and dispensing pharmacy to deliver your care. We never sell it.
Care is available in states where independent, licensed clinicians on the platform can see patients. Select your state when you get started and we'll confirm availability.
Start with a short, secure assessment. A licensed clinician will review it and talk through your options — no commitment.